Xanthines and their therapeutic use

Details Xanthines and their therapeutic use Xanthines and their therapeutic use

1996-05-20

1998-10-13

Berch, Mark L.

Organic compounds -- part of the class 532-570 series

Organic compounds

Chalcogen bonded directly to ring carbon of the purine ring...

544118, 544268, 544269, 544270, 544271, 544272, 544273, 544310, 544311, C07D47306, C07D47304, C07D239545, A61K 3152

Patent

active

058213660

ABSTRACT:
1,3-Disubstituted-zanthines have therapeutic utility via TNF or phosphodiesterase inhibition.

REFERENCES:
patent: 5223504 (1993-06-01), Noverola
Merlos, Eur. J. Med Chem 25, 653 (1990).
Ram, J. Het Chem 19, 153 (1982).
Jacob, J. Autoimmunity, 5, Suppl A 133 (1992).

Affiliated with

Also associated with

Rating

Xanthines and their therapeutic use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Xanthines and their therapeutic use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Xanthines and their therapeutic use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-314306